1
|
Chen W, Zheng R, Zeng H and Zhang S:
Epidemiology of lung cancer in China. Thorac Cancer. 6:209–215.
2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Burstein HJ and Schwartz RS: Molecular
origins of cancer. N Engl J Med. 358:5272008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Uramoto H and Tanaka F: Recurrence after
surgery in patients with NSCLC. Transl Lung Cancer Res. 3:242–249.
2014.PubMed/NCBI
|
4
|
Rittmeyer A: Quality of life in patients
with NSCLC receiving maintenance therapy. Cancers (Basel).
7:950–962. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Leidinger P, Brefort T, Backes C, Krapp M,
Galata V, Beier M, Kohlhaas J, Huwer H, Meese E and Keller A:
High-throughput qRT-PCR validation of blood microRNAs in non-small
cell lung cancer. Oncotarget. 7:4611–4623. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Balmanno K and Cook SJ: Tumour cell
survival signalling by the ERK1/2 pathway. Cell Death Differ.
16:368–377. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Cox AD and Der CJ: The dark side of Ras:
Regulation of apoptosis. Oncogene. 22:8999–9006. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Cagnol S and Chambard JC: ERK and cell
death: Mechanisms of ERK-induced cell death-apoptosis, autophagy
and senescence. FEBS J. 277:2–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Randhawa H, Kibble K, Zeng H, Moyer MP and
Reindl KM: Activation of ERK signaling and induction of colon
cancer cell death by piperlongumine. Toxicol In Vitro.
27:1626–1633. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung
Y, Komarov AP, Keyomarsi K, Yarden Y and Seger R: Taxol-induced
apoptosis depends on MAP kinase pathways (ERK and p38) and is
independent of p53. Oncogene. 20:147–155. 2001. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lv C, Hong Y, Miao L, Li C, Xu G, Wei S,
Wang B, Huang C and Jiao B: Wentilactone A as a novel potential
antitumor agent induces apoptosis and G2/M arrest of human lung
carcinoma cells, and is mediated by HRas-GTP accumulation to
excessively activate the Ras/Raf/ERK/p53-p21 pathway. Cell Death
Dis. 4:e9522013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu T, Zhao L, Zhang Y, Chen W, Liu D, Hou
H, Ding L and Li X: Ginsenoside 20(S)-Rg3 targets HIF-1α to block
hypoxia-induced epithelial-mesenchymal transition in ovarian cancer
cells. PLoS One. 9:e1038872014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kiefer D and Pantuso T: Panax ginseng. Am
Fam Physician. 68:1539–1542. 2003.PubMed/NCBI
|
14
|
Zhang C, Yu H and Hou J: Effects of 20
(S)-ginsenoside Rh2 and 20 (R)-ginsenoside Rh2 on proliferation and
apoptosis of human lung adenocarcinoma A549 cells. Zhongguo Zhong
Yao Za Zhi. 36:1670–1674. 2011.(In Chinese). PubMed/NCBI
|
15
|
Oh M, Choi YH, Choi S, Chung H, Kim K, Kim
SI, Kim DK and Kim ND: Anti-proliferating effects of ginsenoside
Rh2 on MCF-7 human breast cancer cells. Int J Oncol. 14:869–875.
1999.PubMed/NCBI
|
16
|
Liu YF, Yuan HN, Bi XL, Piao HR, Cao JQ,
Li W, Wang P and Zhao YQ: 25-Methoxylprotopanaxadiol derivatives
and their anti-proliferative activities. Steroids. 78:1305–1311.
2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Qian G, Wang Z, Zhao J, Li D, Gao W, Wang
B, Sui D, Qu X and Chen Y: Synthesis and anti-cancer cell activity
of pseudo-ginsenoside Rh2. Steroids. 92:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Qu X, Qu S, Yu X, Xu H, Chen Y, Ma X and
Sui D: Pseudo-G-Rh2 induces mitochondrial-mediated apoptosis in
SGC-7901 human gastric cancer cells. Oncol Rep. 26:1441–1446.
2011.PubMed/NCBI
|
19
|
Xu HL, Yu XF, Qu SC, Zhang R, Qu XR, Chen
YP, Ma XY and Sui DY: Anti-proliferative effect of Juglone from
Juglans mandshurica Maxim on human leukemia cell HL-60 by inducing
apoptosis through the mitochondria-dependent pathway. Eur J
Pharmacol. 645:14–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Matin MM, Nakhaeizadeh H, Bahrami AR,
Iranshahi M, Arghiani N and Rassouli FB: Ferutinin, an apoptosis
inducing terpenoid from Ferula ovina. Asian Pac J Cancer Prev.
15:2123–2128. 2014. View Article : Google Scholar : PubMed/NCBI
|
21
|
Chen HY, Zhang X, Chen SF, Zhang YX, Liu
YH, Ma LL and Wang LX: The protective effect of 17β-estradiol
against hydrogen peroxide-induced apoptosis on mesenchymal stem
cell. Biomed Pharmacother. 66:57–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Deeb D, Gao X, Jiang H, Janic B, Arbab AS,
Rojanasakul Y, Dulchavsky SA and Gautam SC: Oleanane triterpenoid
CDDO-Me inhibits growth and induces apoptosis in prostate cancer
cells through a ROS-dependent mechanism. Biochem Pharmacol.
79:350–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wang H and Joseph JA: Quantifying cellular
oxidative stress by dichlorofluorescein assay using microplate
reader. Free Radic Biol Med. 27:612–616. 1999. View Article : Google Scholar : PubMed/NCBI
|
24
|
Feng X, Yu W, Zhou F, Chen J and Shen P: A
novel small molecule compound diaporine inhibits breast cancer cell
proliferation via promoting ROS generation. Biomed Pharmacother.
83:1038–1047. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Lee YJ, Cho HN, Soh JW, Jhon GJ, Cho CK,
Chung HY, Bae S, Lee SJ and Lee YS: Oxidative stress-induced
apoptosis is mediated by ERK1/2 phosphorylation. Exp Cell Res.
291:251–266. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang P, Wang YZ, Kagan E and Bonner JC:
Peroxynitrite targets the epidermal growth factor receptor, Raf-1,
and MEK independently to activate MAPK. J Biol Chem.
275:22479–22486. 2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Ringer L, Sirajuddin P, Tricoli L, Waye S,
Choudhry MU, Parasido E, Sivakumar A, Heckler M, Naeem A,
Abdelgawad I, et al: The induction of the p53 tumor suppressor
protein bridges the apoptotic and autophagic signaling pathways to
regulate cell death in prostate cancer cells. Oncotarget.
5:10678–10691. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Tsuruo T, Naito M, Tomida A, Fujita N,
Mashima T, Sakamoto H and Haga N: Molecular targeting therapy of
cancer: Drug resistance, apoptosis and survival signal. Cancer Sci.
94:15–21. 2003. View Article : Google Scholar : PubMed/NCBI
|
30
|
Abraham MC and Shaham S: Death without
caspases, caspases without death. Trends Cell Biol. 14:184–193.
2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Shi C, Zheng DD, Fang L, Wu F, Kwong WH
and Xu J: Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP
via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. Biochim
Biophys Acta. 1820:453–460. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Choi YJ, Yoon JH, Cha SW and Lee SG:
Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute
monocytic leukemia cells via inactivation of the MAPK signaling
pathway. Fitoterapia. 82:911–919. 2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang C, Zhu H, Yang X, Lou J, Zhu D, Lu
W, He Q and Yang B: P53 and p38 MAPK pathways are involved in
MONCPT-induced cell cycle G2/M arrest in human non-small cell lung
cancer A549. J Cancer Res Clin Oncol. 136:437–445. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Shih A, Davis FB, Lin HY and Davis PJ:
Resveratrol induces apoptosis in thyroid cancer cell lines via a
MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab.
87:1223–1232. 2002. View Article : Google Scholar : PubMed/NCBI
|
35
|
Wang X, Martindale JL and Holbrook NJ:
Requirement for ERK activation in cisplatin-induced apoptosis. J
Biol Chem. 275:39435–39443. 2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
Waris G and Ahsan H: Reactive oxygen
species: Role in the development of cancer and various chronic
conditions. J Carcinog. 5:142006. View Article : Google Scholar : PubMed/NCBI
|
37
|
Weinberg F, Hamanaka R, Wheaton WW,
Weinberg S, Joseph J, Lopez M, Kalyanaraman B, Mutlu GM, Budinger
GR and Chandel NS: Mitochondrial metabolism and ROS generation are
essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA.
107:8788–8793. 2010. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wu CL, Huang AC, Yang JS, Liao CL, Lu HF,
Chou ST, Ma CY, Hsia TC, Ko YC and Chung JG: Benzyl isothiocyanate
(BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of
reactive oxygen species causes cell cycle arrest and induces
apoptosis via activation of caspase-3, mitochondria dysfunction and
nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells. J
Orthop Res. 29:1199–1209. 2011. View Article : Google Scholar : PubMed/NCBI
|
39
|
Ge G, Yan Y and Cai H: Ginsenoside Rh2
inhibited proliferation by inducing ROS mediated ER stress
dependent apoptosis in lung cancer cells. Biol Pharm Bull.
40:2117–2124. 2017. View Article : Google Scholar : PubMed/NCBI
|
40
|
Singh DV, Agarwal S, Singh P, Godbole MM
and Misra K: Curcumin conjugates induce apoptosis via a
mitochondrion dependent pathway in MCF-7 and MDA-MB-231 cell lines.
Asian Pac J Cancer Prev. 14:5797–5804. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Matsunaga Y, Kawai Y, Kohda Y and Gemba M:
Involvement of activation of NADPH oxidase and extracellular
signal-regulated kinase (ERK) in renal cell injury induced by zinc.
J Toxicol Sci. 30:135–144. 2005. View Article : Google Scholar : PubMed/NCBI
|
42
|
Ramachandiran S, Huang Q, Dong J, Lau SS
and Monks TJ: Mitogen-activated protein kinases contribute to
reactive oxygen species-induced cell death in renal proximal tubule
epithelial cells. Chem Res Toxicol. 15:1635–1642. 2002. View Article : Google Scholar : PubMed/NCBI
|
43
|
Woessmann W, Chen X and Borkhardt A:
Ras-mediated activation of ERK by cisplatin induces cell death
independently of p53 in osteosarcoma and neuroblastoma cell lines.
Cancer Chemother Pharmacol. 50:397–404. 2002. View Article : Google Scholar : PubMed/NCBI
|
44
|
DeHaan RD, Yazlovitskaya EM and Persons
DL: Regulation of p53 target gene expression by cisplatin-induced
extracellular signal-regulated kinase. Cancer Chemother Pharmacol.
48:383–388. 2001. View Article : Google Scholar : PubMed/NCBI
|
45
|
Kim GS, Hong JS, Kim SW, Koh JM, An CS,
Choi JY and Cheng SL: Leptin induces apoptosis via
ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells.
J Biol Chem. 278:21920–21929. 2003. View Article : Google Scholar : PubMed/NCBI
|
46
|
Li DW, Liu JP, Mao YW, Xiang H, Wang J, Ma
WY, Dong Z, Pike HM, Brown RE and Reed JC: Calcium-activated
RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and
is abrogated by alpha B-crystallin through inhibition of RAS
activation. Mol Biol Cell. 16:4437–4453. 2005. View Article : Google Scholar : PubMed/NCBI
|
47
|
Liu J, Mao W, Ding B and Liang CS:
ERKs/p53 signal transduction pathway is involved in
doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am
J Physiol Heart Circ Physiol. 295:H1956–H1965. 2008. View Article : Google Scholar : PubMed/NCBI
|
48
|
Wu Z, Wu LJ, Tashiro S, Onodera S and
Ikejima T: Phosphorylated extracellular signal-regulated kinase
up-regulated p53 expression in shikonin-induced HeLa cell
apoptosis. Chin Med J (Engl). 118:671–677. 2005.PubMed/NCBI
|